Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Video

» Interview

Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism

September 19, 2022

Video

» Interview

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

September 18, 2022

Video

» Interview

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

September 18, 2022

Video

» Interview

Contemporary Clinical and Echocardiographic Outcomes of 1000+ Patients Treated With MitraClip™ G4: Results From the EXPAND G4 Post Approval Study

September 18, 2022

Video

» Interview

CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings

September 18, 2022

Video

» Interview

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

September 17, 2022

Video

» Interview

3-Year Outcomes from the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)

September 17, 2022

Video

» Interview

The Value of FEops HEARTguide™ Computational Modeling in the Planning of Percutaneous LAA Closure - The PREDICT LAA Trial

September 17, 2022

Video

» Interview

Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates from the Intrepid Pilot Study

September 17, 2022

Video

» Interview

Updated Cumulative Results of Treatment with Mavacamten from the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients with Obstructive Hypertrophic Cardiomyopathy

May 4, 2022

Video

» Interview

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

May 4, 2022

Video

» Interview

SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure

May 4, 2022

Video

» Interview

METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction

May 4, 2022

Video

» Interview

GIPS-IV: The Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate After St-segment Elevation Myocardial Infarction

May 4, 2022

Video

» Interview

EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries

May 4, 2022

Video

» Interview

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

May 4, 2022

Video

» Interview

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

May 4, 2022

Video

» Interview

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

April 3, 2022

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Video

» Interview

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

April 3, 2022

Advertisement

Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Contemporary Clinical and Echocardiographic Outcomes of 1000+ Patients Treated With MitraClip™ G4: Results From the EXPAND G4 Post Approval Study

CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

3-Year Outcomes from the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)

The Value of FEops HEARTguide™ Computational Modeling in the Planning of Percutaneous LAA Closure - The PREDICT LAA Trial

Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates from the Intrepid Pilot Study

Updated Cumulative Results of Treatment with Mavacamten from the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients with Obstructive Hypertrophic Cardiomyopathy

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure

METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction

GIPS-IV: The Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate After St-segment Elevation Myocardial Infarction

EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content